Selective disruption of RORγt-CBFβ interaction by IMU-935 prevents RORγt-dependent Th17 autoimmunity but not thymocyte development

Journal:

Journal of Clinical Investigation

Published:

2026-01-02

DOI:

10.1172/jci185942

Affiliations:

8

Authors:

19

Go to article

Institutions	Authors	Share
City of Hope, United States of America (USA)	10.000000 10.000000	0.53
Immunic, Germany	5.000000	0.26
Beckman Research Institute, City of Hope, United States of America (USA)	1.000000	0.05
UCLA Health, United States of America (USA)	1.000000	0.05
RIKEN Center for Integrative Medical Sciences (IMS), Japan	1.000000	0.05
Hackensack University Medical Center (Hackensack UMC), United States of America (USA)	1.000000	0.05

Interested in Immunology?